GleamWall
中文EN

CDXS CODEXIS, INC.

Industrial Organic Chemicals · Nasdaq · SEC CIK 1200375 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY66.9%
TTM net income YoY69.9%
TTM EPS YoY75.3%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR—

Margins

Gross margin86.8%
Operating margin-18.3%
Net margin-21.8%
FCF margin-13.7%
EBITDA margin-12.6%

Returns

ROE-42.9%
ROA-14.3%
ROIC (approx.)-22.0%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets64.5%
Debt / equity0.81x
Current ratio2.81x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.54x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue1.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$19.26M$14.91M$15.25M$38.91M$8.60M$15.33M$7.54M$21.46M
Cost of revenue$4.01M$3.51M$2.06M$2.04M$2.46M$2.10M$2.73M$3.65M
Gross profit$15.25M$11.40M$13.18M$36.87M$6.14M$13.23M$4.81M$17.81M
R&D expense$12.59M$11.71M$11.45M$11.72M$13.87M$13.78M$12.94M$12.10M
SG&A expense$10.10M$10.93M$9.78M$11.19M$11.22M$12.32M$12.36M$13.05M
Operating income-$7.44M-$11.23M-$8.04M$10.56M-$18.95M-$12.86M-$20.49M-$7.34M
Pretax income-$8.12M-$11.99M-$8.67M$9.62M-$19.61M-$13.26M-$20.68M-$10.37M
Income tax$9,000$10,000$36,000$18,000$8,000$10,000$11,000$3,000
Net income-$8.13M-$12.01M-$8.70M$9.60M-$19.61M-$13.27M-$20.69M-$10.38M
EBITDA-$6.30M-$10.03M-$6.76M$11.92M-$17.63M-$11.56M-$19.29M-$6.13M
EPS (basic)-0.08-0.13-0.10—-0.22-0.16-0.25—
EPS (diluted)-0.08-0.13-0.10—-0.22-0.16-0.25—
Weighted avg. shares (diluted)107.26M91.05M90.77M—90.25M85.39M82.41M—
Balance sheet
Cash & equivalents$29.21M$27.17M$36.57M$50.79M$25.35M$26.76M$18.32M$20.83M
Short-term investments$43.45M$27.75M$28.57M$27.42M$33.35M$39.57M$41.50M$54.19M
Inventory$2.10M$1.60M$2.00M$1.82M$1.94M$1.95M$1.78M$1.80M
Current assets$95.77M$71.92M$79.65M$96.82M$76.19M$88.73M$77.81M$98.77M
PP&E, net$13.33M$11.91M$12.59M$13.02M$14.01M$14.98M$15.80M$14.20M
Goodwill$2.46M$2.46M$2.46M$2.46M$2.46M$2.46M$2.46M$2.46M
Total assets$144.22M$120.06M$129.37M$147.80M$123.96M$138.25M$128.89M$149.01M
Current liabilities$34.09M$23.51M$14.85M$25.32M$18.48M$15.24M$20.90M$23.65M
Short-term debt$11.79M$7.06M—$0————
Long-term debt$29.48M$33.82M$40.48M$40.10M$39.73M$39.37M$29.19M$28.91M
Total debt$41.28M$40.88M$40.48M$40.10M$39.73M$39.37M$29.19M$28.91M
Total liabilities$92.98M$87.10M$86.14M$97.27M$85.42M$82.61M$79.26M$82.08M
Shareholders' equity$51.24M$32.96M$43.23M$50.53M$38.54M$55.63M$49.63M$66.93M
Net debt$12.06M$13.70M$3.91M-$10.69M$14.38M$12.61M$10.87M$8.08M
Shares outstanding109.52M91.39M90.89M90.48M90.28M90.25M82.84M81.85M
Cash flow statement
Operating cash flow-$7.77M-$9.64M-$13.15M$20.09M-$7.70M-$17.97M-$13.80M-$16.47M
Capital expenditure$74,000$898,000$176,000$520,000$182,000$2.51M$1.25M$1.77M
Free cash flow-$7.84M-$10.54M-$13.33M$19.57M-$7.88M-$20.48M-$15.05M-$18.24M
Investing cash flow-$15.61M$175,000-$1.11M$5.71M$6.39M-$367,000$11.77M-$2.86M
Financing cash flow$25.00M$66,000-$14,000$180,000-$111,000$26.77M$1.08M$1.13M
Depreciation & amortization$1.14M$1.20M$1.29M$1.36M$1.32M$1.30M$1.20M$1.21M
Stock-based compensation$1.55M$1.58M$1.43M$2.20M$2.51M$2.53M$2.38M$2.53M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.